CHD2 and Global developmental delay: Together, the consistent clinical features among patients diagnosed by routine clinical microarray and the de novo occurrence of all deletions affecting CHD2 reported thus far support a causative role of CHD2 haploinsufficiency for developmental delay, intellectual disability, epilepsy and behavioural problems, with phenotypic variability among individuals (Table 1).